• Publications
  • Influence
Update on burning mouth syndrome: overview and patient management.
Burning Mouth Syndrome (BMS) is a chronic pain syndrome that mainly affects middle-aged/old women with hormonal changes or psychological disorders. This condition is probably of multifactorialExpand
  • 412
  • 46
A classification of chronic pain for ICD-11
Chronic pain has been recognized as pain that persists past normal healing time5 and hence lacks the acute warning function of physiological nociception.35 Usually pain is regarded as chronic when itExpand
  • 688
  • 28
Pain threshold variations in somatic wall tissues as a function of menstrual cycle, segmental site and tissue depth in non-dysmenorrheic women, dysmenorrheic women and men
Abstract Pain symptoms of many disorders are reported to vary with menstrual stage. This study investigated how pain thresholds to electrical stimulation of the skin, subcutis and muscle tissueExpand
  • 233
  • 11
Viscero-visceral hyperalgesia: Characterization in different clinical models
&NA; Co‐existing algogenic conditions in two internal organs in the same patient may mutually enhance pain symptoms (viscero‐visceral hyperalgesia). The present study assessed this phenomenon inExpand
  • 125
  • 5
Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma.
The thiobarbituric acid (TBA) reactivity of human plasma was studied to evaluate its adequacy in quantifying lipid peroxidation as an index of systemic oxidative stress. Two spectrophotometric TBAExpand
  • 197
  • 5
Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia
&NA; In a rat model of artificial ureteral calculosis, the aim of the study was to characterize the behavioural manifestations of direct visceral pain and to evaluate the relationship between number,Expand
  • 131
  • 4
Antioxidant properties of ursodeoxycholic acid.
We have investigated potential antioxidant properties of the clinically relevant bile acid UDCA, which reaches therapeutic concentrations up to 0.09 and 29 mM, respectively, in human plasma and bile.Expand
  • 71
  • 4
Effects of treatment of peripheral pain generators in fibromyalgia patients
Fibromyalgia syndrome (FS) frequently co‐occurs with regional pain disorders. This study evaluated how these disorders contribute to FS, by assessing effects of local active vs placebo treatment ofExpand
  • 109
  • 4
Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)
Abstract Chronic pain is a major source of suffering. It interferes with daily functioning and often is accompanied by distress. Yet, in the International Classification of Diseases, chronic painExpand
  • 122
  • 4
Effects of the novel anti‐inflammatory compounds, N‐[2‐(cyclohexyloxy)‐4‐nitrophenyl] methanesulphonamide (NS‐398) and 5‐methanesulphonamido‐6‐(2, 4‐difluorothiophenyl)‐1‐indanone (L‐745, 337), on
1 We have evaluated the selectivity of ketoprofen and two novel nonsteroidal anti‐inflammatory drugs, N‐[2‐(cyclohexyloxy)‐4‐nitrophenyl]methanesulphonamide (NS‐398) and 5‐methanesulphonamido‐6‐(2,Expand
  • 57
  • 4